Anxious to Launch a Vaccine is Blocked, Trump is Anxious : The White House may Veto the FDA to Tighten Vaccine Standards

According to Russian media reports, on September 23 local time, U.S. President Trump declared in an interview that the US Food and Drug Administration (FDA) tightened the new coronavirus vaccine approval standards. A 'political move', he may veto the FDA's regulations on the approval standards for the new coronavirus vaccine.

According to reports, Trump said, 'We are studying this issue, which must be approved by the White House, and we may or may not approve it.'

He said, 'When Pfizer, Johnson & Johnson, Modena and other pharmaceutical companies are developing vaccines and conducting a large number of trials and all other preparations, why extend the approval process to keep people sick?' Trump said, 'Vaccines are very important, and I think we will make a final decision soon.' At the same time, the American leader also accused the FDA of tightening approval standards as a 'political move' and not because of anything else.

In addition, Trump also announced that the U.S. government plans to allocate $200 million to help states distribute the new coronavirus vaccine. He said, 'My government will announce a total of 200 million U.S. dollars to all states to help localities prepare for the distribution of vaccines to all classes of people at high risk of infection. We hope that this money will be in place after the vaccine is approved.'

Trump has stated many times before that the new coronavirus vaccine in the United States will be ready soon, and promised to distribute 100 million doses of vaccine across the United States by the end of this year. He said the vaccine may be distributed before the November 3 presidential election.

Many scholars worry that Trump's attempt to speed up the vaccine approval process will cause people to worry about vaccine safety. According to U.S. media reports on the 22nd, the FDA will announce new standards for the new coronavirus vaccine. This is to increase the confidence of the American people. However, US media pointed out that stricter requirements will prevent the vaccine from being approved before the US election.